ID   4EBP1_RAT               Reviewed;         117 AA.
AC   Q62622;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 158.
DE   RecName: Full=Eukaryotic translation initiation factor 4E-binding protein 1;
DE            Short=4E-BP1;
DE            Short=eIF4E-binding protein 1;
DE   AltName: Full=Phosphorylated heat- and acid-stable protein regulated by insulin 1;
DE            Short=PHAS-I;
GN   Name=Eif4ebp1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116 {ECO:0000312|EMBL:AAA86938.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 18-33; 43-53; 62-80 AND
RP   98-117, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley {ECO:0000269|PubMed:8170978};
RC   TISSUE=Adipocyte {ECO:0000269|PubMed:8170978}, and
RC   Skeletal muscle {ECO:0000312|EMBL:AAA86938.1};
RX   PubMed=8170978; DOI=10.1073/pnas.91.9.3730;
RA   Hu C., Pang S., Kong X., Velleca M., Lawrence J.C. Jr.;
RT   "Molecular cloning and tissue distribution of PHAS-I, an intracellular
RT   target for insulin and growth factors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3730-3734(1994).
RN   [2]
RP   FUNCTION, INTERACTION WITH EIF4E, PHOSPHORYLATION AT SER-64 BY MAPK1 AND
RP   MAPK3, AND MUTAGENESIS OF SER-64.
RX   PubMed=7939721; DOI=10.1126/science.7939721;
RA   Lin T.-A., Kong X., Haystead T.A.J., Pause A., Belsham G.J., Sonenberg N.,
RA   Lawrence J.C. Jr.;
RT   "PHAS-I as a link between mitogen-activated protein kinase and translation
RT   initiation.";
RL   Science 266:653-656(1994).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-36, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Repressor of translation initiation that regulates EIF4E
CC       activity by preventing its assembly into the eIF4F complex:
CC       hypophosphorylated form competes with EIF4G1/EIF4G3 and strongly binds
CC       to EIF4E, leading to repress translation. In contrast,
CC       hyperphosphorylated form dissociates from EIF4E, allowing interaction
CC       between EIF4G1/EIF4G3 and EIF4E, leading to initiation of translation
CC       (By similarity). Mediates the regulation of protein translation by
CC       hormones, growth factors and other stimuli that signal through the MAP
CC       kinase and mTORC1 pathways (PubMed:7939721).
CC       {ECO:0000250|UniProtKB:Q13541, ECO:0000269|PubMed:7939721}.
CC   -!- SUBUNIT: Hypophosphorylated EIF4EBP1 competes with EIF4G1/EIF4G3 to
CC       interact with EIF4E; insulin stimulated MAP-kinase (MAPK1 and MAPK3) or
CC       mTORC1 phosphorylation of EIF4EBP1 causes dissociation of the complex
CC       allowing EIF4G1/EIF4G3 to bind and consequent initiation of translation
CC       (PubMed:7939721). Interacts (via TOS motif) with RPTOR; promoting
CC       phosphorylation by mTORC1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q13541, ECO:0000269|PubMed:7939721}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q60876}. Nucleus
CC       {ECO:0000250|UniProtKB:Q60876}. Note=Localization to the nucleus is
CC       unaffected by phosphorylation status. {ECO:0000250|UniProtKB:Q60876}.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined; highest levels
CC       in fat and skeletal tissue, lowest levels in kidney.
CC       {ECO:0000269|PubMed:7939721, ECO:0000269|PubMed:8170978}.
CC   -!- DOMAIN: The TOS motif mediates interaction with RPTOR, leading to
CC       promote phosphorylation by mTORC1 complex.
CC       {ECO:0000250|UniProtKB:Q13541}.
CC   -!- PTM: Phosphorylated on serine and threonine residues in response to
CC       insulin, EGF and PDGF. Phosphorylation at Thr-36, Thr-45, Ser-64 and
CC       Thr-69, corresponding to the hyperphosphorylated form, is regulated by
CC       mTORC1 and abolishes binding to EIF4E. {ECO:0000269|PubMed:7939721,
CC       ECO:0000269|PubMed:8170978}.
CC   -!- PTM: Ubiquitinated: when eIF4E levels are low, hypophosphorylated form
CC       is ubiquitinated by the BCR(KLHL25) complex, leading to its degradation
CC       and serving as a homeostatic mechanism to maintain translation and
CC       prevent eIF4E inhibition when eIF4E levels are low. Not ubiquitinated
CC       when hyperphosphorylated (at Thr-36, Thr-45, Ser-64 and Thr-69) or
CC       associated with eIF4E. {ECO:0000250|UniProtKB:Q13541}.
CC   -!- SIMILARITY: Belongs to the eIF4E-binding protein family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U05014; AAA86938.1; -; mRNA.
DR   PIR; A55258; A55258.
DR   RefSeq; NP_446309.1; NM_053857.2.
DR   AlphaFoldDB; Q62622; -.
DR   SMR; Q62622; -.
DR   BioGRID; 250521; 7.
DR   DIP; DIP-267N; -.
DR   ELM; Q62622; -.
DR   MINT; Q62622; -.
DR   STRING; 10116.ENSRNOP00000016885; -.
DR   ChEMBL; CHEMBL5169161; -.
DR   GlyGen; Q62622; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q62622; -.
DR   PhosphoSitePlus; Q62622; -.
DR   PaxDb; 10116-ENSRNOP00000016885; -.
DR   Ensembl; ENSRNOT00000096679.1; ENSRNOP00000087155.1; ENSRNOG00000012582.6.
DR   Ensembl; ENSRNOT00055013467; ENSRNOP00055010788; ENSRNOG00055007988.
DR   Ensembl; ENSRNOT00060020858; ENSRNOP00060016441; ENSRNOG00060012306.
DR   Ensembl; ENSRNOT00065003710; ENSRNOP00065002588; ENSRNOG00065002728.
DR   GeneID; 116636; -.
DR   KEGG; rno:116636; -.
DR   UCSC; RGD:620259; rat.
DR   AGR; RGD:620259; -.
DR   CTD; 1978; -.
DR   RGD; 620259; Eif4ebp1.
DR   eggNOG; ENOG502S4SY; Eukaryota.
DR   GeneTree; ENSGT00940000159932; -.
DR   HOGENOM; CLU_111706_0_0_1; -.
DR   InParanoid; Q62622; -.
DR   OMA; NTDHSVH; -.
DR   OrthoDB; 2911937at2759; -.
DR   PhylomeDB; Q62622; -.
DR   TreeFam; TF101530; -.
DR   Reactome; R-RNO-166208; mTORC1-mediated signalling.
DR   Reactome; R-RNO-72662; Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S.
DR   PRO; PR:Q62622; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000012582; Expressed in pancreas and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISS:AgBase.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0008190; F:eukaryotic initiation factor 4E binding; IPI:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IPI:RGD.
DR   GO; GO:0031369; F:translation initiation factor binding; IPI:RGD.
DR   GO; GO:0030371; F:translation repressor activity; ISS:UniProtKB.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0002192; P:IRES-dependent translational initiation of linear mRNA; ISO:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0031333; P:negative regulation of protein-containing complex assembly; IMP:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:RGD.
DR   GO; GO:0045947; P:negative regulation of translational initiation; IMP:RGD.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:1990928; P:response to amino acid starvation; IDA:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:0031929; P:TOR signaling; ISS:UniProtKB.
DR   InterPro; IPR008606; EIF4EBP.
DR   PANTHER; PTHR12669; EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN; 1.
DR   PANTHER; PTHR12669:SF14; EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 1; 1.
DR   Pfam; PF05456; eIF_4EBP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Direct protein sequencing; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Protein synthesis inhibitor; Reference proteome;
KW   Translation regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   CHAIN           2..117
FT                   /note="Eukaryotic translation initiation factor 4E-binding
FT                   protein 1"
FT                   /id="PRO_0000190515"
FT   REGION          1..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          64..117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           53..59
FT                   /note="YXXXXLphi motif"
FT                   /evidence="ECO:0000250|UniProtKB:P70445"
FT   MOTIF           113..117
FT                   /note="TOS motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   COMPBIAS        1..15
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        33..47
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        78..97
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        98..117
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         36
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         40
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         43
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60876"
FT   MOD_RES         45
FT                   /note="Phosphothreonine; by MTOR"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         49
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         53
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         64
FT                   /note="Phosphoserine; by DYRK2, MAPK1, MAPK3 and MTOR"
FT                   /evidence="ECO:0000269|PubMed:7939721"
FT   MOD_RES         69
FT                   /note="Phosphothreonine; by MTOR"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         76
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         95
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60876"
FT   MOD_RES         99
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60876"
FT   MOD_RES         100
FT                   /note="Phosphoserine; by DYRK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MOD_RES         111
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   CROSSLNK        56
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   MUTAGEN         64
FT                   /note="S->A: Decreases phosphorylation by MAPK1 and MAPK3."
FT                   /evidence="ECO:0000269|PubMed:7939721"
FT   CONFLICT        19
FT                   /note="R -> N (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        69
FT                   /note="T -> P (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        75
FT                   /note="P -> L (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   117 AA;  12404 MW;  3449D57B09FA101A CRC64;
     MSAGSSCSQT PSRAIPTRRV ALGDGVQLPP GDYSTTPGGT LFSTTPGGTR IIYDRKFLME
     CRNSPVAKTP PKDLPTIPGV TSPTSDEPPM QASQSHLHSS PEDKRAGGEE SQFEMDI
//
